169 related articles for article (PubMed ID: 4157882)
1. [On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea (C 73)].
Gerhartz H; Staeuber PG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):54-61. PubMed ID: 4157882
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of chronic lymphocytic leukemia].
Gerhartz H
Med Klin; 1967 Aug; 62(32):1237-9. PubMed ID: 4969643
[No Abstract] [Full Text] [Related]
3. [Results of experimental and clinical studies of a new antileukemic drug: hexaphosphamide. Review of the literature and the author's own results].
Khomchenovskii EI
Haematologia (Budap); 1977; 11(1-2):115-26. PubMed ID: 352850
[No Abstract] [Full Text] [Related]
4. [Indomethacin and hematopoiesis. Antipyretic and antiphlogistic effects in hemoblastoses and various uncommon diseases].
Treske U
Med Klin; 1968 Mar; 63(9):344-6. PubMed ID: 5247178
[No Abstract] [Full Text] [Related]
5. [Use of Imiphos in diseases of the blood system].
Pinus AG
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):26-31. PubMed ID: 5260223
[No Abstract] [Full Text] [Related]
6. The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.
Bodrogi I; Bálint I
Ther Hung; 1979; 27(2):77-83. PubMed ID: 494144
[No Abstract] [Full Text] [Related]
7. [Rehabilitation and cure of patients with hemoblastoses].
Gerhartz H
Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782
[No Abstract] [Full Text] [Related]
8. [Drug therapy in hemoblastosis].
Bischof B
Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
[No Abstract] [Full Text] [Related]
9. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
Cheţa D; Micu D; Cheţa N
Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
[No Abstract] [Full Text] [Related]
10. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
11. [Use of the Soviet preparations, fotrin and imifos, in erythremia].
Petrov KIa; Buglaev AP
Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):14-6. PubMed ID: 7413620
[No Abstract] [Full Text] [Related]
12. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
13. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
14. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
15. [Use of hexaphosphamide for the treatment of myelocytic leukemia].
Nevskaia TP; Levitin EI; Mokeeva RA; Faĭnshteĭn FE
Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):57. PubMed ID: 1071794
[No Abstract] [Full Text] [Related]
16. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
17. [Life expectancy of hemoblastosis patients].
Obrecht P
Med Klin; 1966 Dec; 61(50):1985-90. PubMed ID: 5239386
[No Abstract] [Full Text] [Related]
18. [Treatment of erythremia with imifos (10-year experience with hospital and ambulatory treatment of patients)].
Demidova AV; Shcherbak EM; Kozlova AF
Ter Arkh; 1975; 47(1):56-62. PubMed ID: 1114449
[No Abstract] [Full Text] [Related]
19. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
Kamen BA; Holcenberg JS; Siegel SE
Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
[No Abstract] [Full Text] [Related]
20. [Principles of current chemotherapy of lymphocytic leukemia (review of the literature)].
Ogonovskiĭ TM
Vrach Delo; 1979 Jan; (1):36-41. PubMed ID: 106553
[No Abstract] [Full Text] [Related]
[Next] [New Search]